Specific Targeting of PEGylated Liposomal Doxorubicin (Doxil^®) to Tumour Cells Using a Novel TIMP3 Peptide.

This difference in staining between the cell lines and the primary microvascular endothelial cells was highly significant, as illustrated in Figure 2 E. 3.3.

also in 132,142 other papers